MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The PDCogniCare Toolkit: Developing a harmonised neuropsychological toolkit specific to Parkinson’s Disease

E. Mccann, D. Pourzinal, D. Sriram, L. Mitchell, J. Liddle, A. Lehn, N. Dissanayaka (Herston, Australia)

Meeting: 2025 International Congress

Keywords: Cognitive dysfunction, Parkinson’s

Category: Parkinson's Disease: Cognition / Psychiatric Manifestations / Lewy Body Dementia

Objective: To critically evaluate neuropsychological measures predictive of cognitive decline in Parkinson’s disease (PD) with the aim of proposing a comprehensive, evidence-based neuropsychological toolkit specific to PD.

Background: There is substantial heterogeneity in the cognitive profiles of people living with PD, possibly reflecting variability in neuropsychological measures more commonly used for diagnostic purposes. The harmonisation of cognitive measures is critical to standardise neuropsychological methodology, increase diagnostic accuracy of cognitive disorders, and improve provision of care in those living with PD.

Method: Our previous systematic review identified 11 neuropsychological measures predictive of cognitive decline in PD. To develop these into a comprehensive test battery, the present narrative review provides a practical critique of these measures and explores their application in a PD context.

Results: Psychometric properties of the measures demonstrated good reliability and validity for use in PD. The applications of the measures were explored in relation to clinical and motor symptoms of PD. This included scoring systems and alternative test forms to account for motor interference. Key considerations for the impact of neuropsychiatric symptoms of PD (e.g., depression, anxiety, apathy, sleep disorders) and other clinical features (e.g., medications, fluctuations, insight, activities of daily living) on neuropsychological test performance were explored. Recommendations for implementation of the toolkit were provided to improve quality of assessments and minimise confounds.

Conclusion: We propose a harmonised, evidence-based neuropsychological toolkit tailored for people living with PD to improve the identification of cognitive impairment. Understanding the multifaceted nature of cognitive impairment in PD is key to developing effective neuropsychological assessment procedures and will allow for earlier and more effective diagnosis of cognitive disorders.

To cite this abstract in AMA style:

E. Mccann, D. Pourzinal, D. Sriram, L. Mitchell, J. Liddle, A. Lehn, N. Dissanayaka. The PDCogniCare Toolkit: Developing a harmonised neuropsychological toolkit specific to Parkinson’s Disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/the-pdcognicare-toolkit-developing-a-harmonised-neuropsychological-toolkit-specific-to-parkinsons-disease/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-pdcognicare-toolkit-developing-a-harmonised-neuropsychological-toolkit-specific-to-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley